Trypanosoma cruzi: Protective immunity in mice immunized with paraflagellar rod proteins is associated with a T-helper type 1 response

Experimental Parasitology

Volumn 84, Issue 2, 1996, Pages 156-167

  Miller, Mark J ^a,b   Wrightsman, Ruth A ^a   Manning, Jerry E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Saddleback College   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARASITE ANTIGEN; TRYPANOSOMA VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; FEMALE; HELPER CELL; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRYPANOSOMA CRUZI;

ANIMALIA; RICKETTSIA SP. PAR; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0030298228     PISSN: 00144894     EISSN: None     Source Type: Journal    
DOI: 10.1006/expr.1996.0101     Document Type: Article

References (41)

1. AFONSO, L. C. C., SCHARTON, T. M., VIEIRA, L. Q., WYSOCKA, M., TRINCHIERI, G., AND SCOTT, P. 1994. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263, 235-237.
2. ARAUJO, F. G. 1989. Development of resistance to Trypanosoma cruzi in mice depends on a viable population of L3T4+ (CD4+) lymphocytes. Infection and Immunity 57, 2246-2248.
3. CULBERTSON, J. T., AND KOLODNY, M. H. 1938. Acquired immunity in rats against Trypanosoma cruzi. Journal of Parasitology 24, 83-87.
4. DE TITIO, E. H., CATTERALL, J. R., AND REMINGTON, J. S. 1986. Activity of recombinant tumor necrosis factor on Toxoplasma gondii and Trypanosoma cruzi. Journal of Immunology 137, 1342-1345.
5. GAZZINELLI, R., OSWALD, I., HIENY, S., JAMES, S., AND SHER, A. 1992. The microbicidal activity of interferon-γ-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-β. European Journal of Immunology 22, 2501-2506.
6. JIMÉNEZ DE BAGÜÉS, M. P., ELZER, P. H., BLASCO, J. M., MARIN, C. M., GAMAZO, C., AND WINTER, A. J. 1994. Protective immunity to Brucella ovis in BALB/c mice following recovery from primary infection or immunization with subcellular vaccines. Infection and Immunity 62, 632-638.
7. JULIUS, M. H., SIMPSON, E., AND HERZENBERG, L. A. 1973. A rapid method for the isolation of functional thymus-derived lymphocytes. European Journal of Immunology 3, 645-649.
8. KIERSZENBAUM, F., AND HOWARD, J. G. 1976. Mechanisms of resistance against Trypanosoma cruzi infection: The importance of antibodies and antibody forming capacity in biozzi high and low responder mice. Journal of Immunology 116, 1208-1211.
9. KIERSZENBAUM, F., AND PIENKOWSKI, M. 1979. Thymus-dependent control of host defense mechanisms against Trypanosoma cruzi. Infection and Immunity 24, 117-120.
10. KRETTLI, A. U., AND BRENER, Z. 1976. Protective effects of specific antibodies in Trypanosoma cruzi infections. Journal of Immunology 116, 755-760.
11. KUHN, R., RAJEWSKY, K., AND MULLER W. 1991. Generation and analysis of interleukin-4 deficient mice. Science 254, 707-710.
12. LANAR, D. 1979. Growth and isolation of Trypanosoma cruzi cultivated with Triatoma infestans embryo cell line. Journal of Protozology 26, 457-462.
13. MCCABE, R. E., MEAGHER, S. G., AND MULLINS, B. T. 1991. Endogenous interferon γ, macrophage activation, and murine host defense against acute infection with Trypanosoma cruzi. Journal of Infectious Disease 163, 912-915.
14. MILLER, M. A., SKEEN, M. J., AND ZIEGLER, H. K. 1995. Nonviable bacterial antigens administered with IL-12 generate antigen-specific T cell responses and protective immunity against Listeria monocytogenes. Journal of Immunology 155, 4817-4828.
15. MINOPRIO, P., COUTINHO, A., JOSKOWICZ, M., D'IMPERIOLIMA, M. R., AND EISEN, H. 1986. Polyclonal lymphocyte responses to murine Trypanosoma cruzi infection. II. Cytotoxic T lymphocytes. Scandinavian Journal of Immunology 24, 669-679.
16. MINOPRIO, P., CHEIKH, M. C. E., MURPHY, E., HONTEBEYRIE-JOSKOWICZ, M., COFFMAN, R., COUTINHO, A., AND O'GARRA, A. 1993. Xid-associated resistance to experimental Chagas' disease is "γIFN-dependent. Journal of Immunology 151, 4200-4208.
17. MUÑOZ-FERNANDEZ, M. A., FERNANDEZ, M. A., AND FRESNO, M. 1992. Synergism between tumor necrosis factor and interferon-γ on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. European Journal of Immunology 22, 301-307.
18. PETRAY, P., ROTTENBERG, M., GRINSTEIN, S., AND ORN, A. 1994. Release of nitric oxide during experimental infection with Trypanosoma cruzi. Immunology Letters 16, 193-199.
19. PLATA, F., WIETZERBIN, F., PONS, F. G., FALCOFF, E., AND EISEN, H. 1984. Synergistic protection by specific antibodies and interferon against infection by Trypanosoma cruzi in vitro. European Journal of Immunology 14, 930-935.
20. POWELL, M. R., AND WASSON, D. L. 1993. Host genetics and resistance to acute Trypanosoma cruzi infection in mice. I. Antibody isotype profiles. Parasite Immunology 15, 215-221.
21. RAWLINGS, D. J., AND KASLOW, D. C. 1992. Adjuvant independent immune responses to malarial transmission blocking vaccine candidate antigens. Journal of Experimental Medicine 176, 1483-1487.
22. REED, S. G. 1988. In vivo administration of recombinant IFN-γ induces macrophage activation, and prevents acute disease, immunosuppression, and death in experimental Trypanosoma cruzi infection. Journal of Immunology 140, 4342-4347.
23. REED, S. G., NATHAN, C. F., PIHL, D. L, RODRICKS, P., SHANEBECK, K., CONLON, P. J., AND GRABSTEIN, K. H. 1987. Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Try-panosoma cruzi and release hydrogen peroxide: Comparison to interferon-γ. Journal of Experimental Medicine 166, 1734-1746.
24. RODRIGUEZ, A. M., SANTOR, F., AFCHAIN, D., BAZIN, H., AND CAPRON, A. 1981. Trypanosoma cruzi infection in B-cell deficient rats. Infection and Immunity 31, 524-529.
25. ROTTENBERG, M., CARDONI R., ANDERSSON, R., SEGURA E., AND ORN, A. 1988. Role of T helper/inducer cells as well as natural killer cells in resistance to Trypanosoma cruzi infection. Scandinavian Journal of Immunology 28, 573-582.
26. ROTTENBERG, M. F., BAKHIET, M., OLSSON, T., KRISTENSSON, K., MAK, T., WIGZELL, H., AND ORN, A. 1993. Differential susceptibility of mice genomically deleted of CD4 or CD8 to infections with Trypanosoma cruzi or Trypanosoma brucei. Infection and Immunity 61, 5129-5133.
27. ROTTENBERG, M. F., SPORRONG, L., PERSSON, I., WIGZELL, H., AND ORN, A. 1995. Cytokine gene expression during infection of mice lacking CD4 and/or CD8 with Trypanosoma cruzi. Scandinavian Journal of Immunology 41, 164-170.
28. ROWLAND, E. C., MIKHAIL, K. S., AND MCCORMICK, T. S. 1992. Isotype determination of anti-Trypanosoma cruzi antibody in murine Chagas' disease. Journal of Parasitology 78, 557-561.
29. RUSSO, M., STAROBINAS, N., MINOPRIO, P., COUTINHO, A., AND JOSKOWICZ, M. 1988. Parasitic load increases and myocardial inflammation decreases in Trypanosoma cruzi-infected mice after inactivation of T helper cells. Annals of the Institute Pasteur in Immunology 139, 225-236.
30. SABORIO, J. L., HERNANDEZ, J. M., NARAYANSWAMI, S., WRIGHTSMAN, R., PALMER, E., AND MANNING, J. E. 1989. Isolation and characterization of paraflagellar proteins from Trypanosoma cruzi. Journal of Biology and Chemistry 264, 4071-4075.
31. SCHMUNIS, G. A., GONZALEZ CAPPA, S., TRAVERSA, O., AND JANOVSKY, J. 1971. The effect of immunodepression due to neonatal thymectomy on infections with Trypanosoma cruzi. Transactions of the Royal Society of Tropical Medicine and Hygiene 65, 89-94.
32. SILVA, J. S., MORISSEY, P. J., GRABSTEIN, K. H., MOHLER, K. M., ANDERSON, D., AND REED, S. G. 1992. Interleukin 10 and interferon γ regulation of experimental Trypanosoma cruzi infection. Journal of Experimental Medicine 175, 169-174.
33. TAKEHARA, H. A., PERINI, A., DA SILVA, M. H., AND MOTA, I. 1981. Trypanosoma cruzi. Role of different antibody classes in protection against infection in the mouse. Experimental Parasitology 52, 137-146.
34. TAKEHARA, H. A., DA SILVA, A. M. M., BRODSKYN, C. I., AND MOTA, I. 1989. A comparative study of anti-Trypanosoma cruzi serum obtained from acute and chronic phase of infection in mice. Immunology Letters 23, 81-86.
35. TARLETON, R. 1990. Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi. Journal of Immunology 144, 717-724.
36. 2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature 356, 338-340.
37. TORRICO, F., HEREMANS, H., RIVERA, M. T., VAN MARCK, E., BILLIAU, A., AND CARLIER, Y. 1991. Endogenous IFN-γ is required for resistance to acute Trypanosoma cruzi infection in mice. Journal of Immunology 146, 3626-3632.
38. WIRTH, J. J., KIERSZENBAUM, K., SONNENFELD, G., AND ZLOTNIK, A. 1985. Enhancing effects of gamma interferon on phagocytic cell association and killing of Trypanosoma cruzi. Infection and Immunity 49, 61-66.
39. WRIGHTSMAN, R., KRASSNER, S., AND WATSON, J. 1982. Genetic control of responses to Trypanosoma cruzi in mice: Multiple genes influencing parasitemia and survival. Infection and Immunity 36, 637-644.
40. WRIGHTSMAN, R. A., MILLER, M. J., SABORIO, J. L, AND MANNING, J. E. 1995. Pure paraflagellar rod protein protects mice against Trypanosoma cruzi infection. Infection and Immunity 63, 121-125.
41. WYNN, T. A., ELTOUM, I., OSWALD, I. P., CHEEVER, A. W., AND SHER, A. 1994. Endogenous interleukin-12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactially immunizes against egg pathology. Journal of Experimental Medicine 179, 1551-1561.